PL2133079T3 - Kompozycje do leczenia infekcji pochwy z przewlekłym zapaleniem - Google Patents

Kompozycje do leczenia infekcji pochwy z przewlekłym zapaleniem

Info

Publication number
PL2133079T3
PL2133079T3 PL08425421T PL08425421T PL2133079T3 PL 2133079 T3 PL2133079 T3 PL 2133079T3 PL 08425421 T PL08425421 T PL 08425421T PL 08425421 T PL08425421 T PL 08425421T PL 2133079 T3 PL2133079 T3 PL 2133079T3
Authority
PL
Poland
Prior art keywords
treatment
compositions
vaginal infections
chronic inflammation
vaginal
Prior art date
Application number
PL08425421T
Other languages
English (en)
Inventor
Ezio Bombardelli
Gabriele Fontana
Andrea Giori
Paolo Morazzoni
Antonella Riva
Massimo Ronchi
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of PL2133079T3 publication Critical patent/PL2133079T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/473Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
PL08425421T 2008-06-12 2008-06-12 Kompozycje do leczenia infekcji pochwy z przewlekłym zapaleniem PL2133079T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08425421A EP2133079B1 (en) 2008-06-12 2008-06-12 Compositions for the treatment of vaginal infections with chronic inflammation

Publications (1)

Publication Number Publication Date
PL2133079T3 true PL2133079T3 (pl) 2012-03-30

Family

ID=39791236

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08425421T PL2133079T3 (pl) 2008-06-12 2008-06-12 Kompozycje do leczenia infekcji pochwy z przewlekłym zapaleniem

Country Status (8)

Country Link
EP (1) EP2133079B1 (pl)
AT (1) ATE526968T1 (pl)
DK (1) DK2133079T3 (pl)
ES (1) ES2371825T3 (pl)
HR (1) HRP20110945T1 (pl)
PL (1) PL2133079T3 (pl)
PT (1) PT2133079E (pl)
SI (1) SI2133079T1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011254804A1 (en) * 2010-05-18 2012-12-06 Indena S.P.A. Compositions for the treatment of gynaecological disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175000A (en) * 1987-06-30 1992-12-29 Vipont Pharmaceutical, Inc. Free amine benzophenanthridine alkaloid compositions
ATE122565T1 (de) * 1990-07-05 1995-06-15 Indena Spa Neolignanderivatkomplexen mit phospolipiden, deren verwendung und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
EP1882473A1 (en) * 2006-07-28 2008-01-30 Indena S.P.A. Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs

Also Published As

Publication number Publication date
DK2133079T3 (da) 2011-12-12
EP2133079B1 (en) 2011-10-05
ATE526968T1 (de) 2011-10-15
ES2371825T3 (es) 2012-01-10
EP2133079A1 (en) 2009-12-16
PT2133079E (pt) 2011-11-28
SI2133079T1 (sl) 2012-01-31
HRP20110945T1 (hr) 2012-01-31
HK1136203A1 (en) 2010-06-25

Similar Documents

Publication Publication Date Title
EP2185514A4 (en) VINYL-ARYL DERIVATIVES FOR INFLAMMATORY AND IMMUNE DISORDERS
WO2008103277A3 (en) Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
PH12014501671B1 (en) Amidine substituted beta-lactam compounds, their preparation and use as antibacterial agents
IL187999A0 (en) Compositions for the treatment of persistent infections
BRPI0915731A2 (pt) composição de graxa.
BRPI0915732A2 (pt) composição de graxa.
WO2010015929A3 (en) Uses of mesenchymal stem cells
WO2009134389A9 (en) An anti-cd137 antibody as an agent in the treatment of inflammatory conditions
WO2010007166A3 (en) Treatment of inflammatory bowel diseases with mammal beta defensins
EP2384250A4 (en) THE EFFICIENCY IMPROVING COMPOSITION
IL213638A0 (en) Novel antibacterial agents for the treatment of gram positive infections
IL189754A0 (en) Use of an aureolysin inhibitor for the treatment of inflammatory skin conditions characterised by colonisation with staphylococcus aureus
BRPI0815003A2 (pt) Uso de um composto, composições, compostos, uso dos mesmos, método de tratamento, melhora ou profilaxia dos sintomas de um distúrbio inflamatório.
PL2293805T3 (pl) Kompozycja do ssania, do leczenia chorób zapalnych jamy ustnej i gardłowej
ZA200807442B (en) Novel use of antihistamine agents for the preventive or early treatment of inflammatory syndromes, in particular those triggered by togaviruses
BRPI0811557A2 (pt) composto, composição farmacêutica, método de tratamento ou profilaxia de uma condição inflamatória.
WO2007084542A3 (en) Treatment of inflammatory disorders with triazole compounds
WO2009129926A8 (en) Compositions for the treatment and prevention of infections of the oral cavity
PL2133079T3 (pl) Kompozycje do leczenia infekcji pochwy z przewlekłym zapaleniem
WO2009129927A8 (en) Compositions for the treatment of vaginal infections with chronic inflammation
WO2012061767A3 (en) Defensin-like molecules as novel antimicrobial agents
WO2011069149A3 (en) Cathepsin s inhibitors
ZA201100468B (en) The treatment of helminthic infections
WO2011038157A3 (en) Zinc-containing compositions for the treatment of diseases, illnesses and syndromes associated with exposure to pore forming toxins
MD3358G2 (ro) 12-Hidroperoxi-8a,12-epoxi-11-bishomodriman pentru utilizare în tratamentul afecţiunilor micotice